- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-7276
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Cancer neoantigens as potential targets for immunotherapy ; day:5 ; month:5 ; year:2021 ; pages:1-10
Clinical & experimental metastasis ; (5.5.2021), 1-10
- Urheber
-
Ma, Weijie
Pham, Brian
Li, Tianhong
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s10585-021-10091-1
- URN
-
urn:nbn:de:101:1-2021090819421079031498
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:21 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ma, Weijie
- Pham, Brian
- Li, Tianhong
- SpringerLink (Online service)
Ähnliche Objekte (12)
Pan-cancer analysis reveals IGFL2 as a potential target for cancer prognosis and immunotherapy
Immune checkpoint molecules in natural killer cells as potential targets for cancer immunotherapy
The Notch signaling pathway: a potential target for cancer immunotherapy
NEK2 is a potential pan-cancer biomarker and immunotherapy target
Revisiting T-cell adhesion molecules as potential targets for cancer immunotherapy: CD226 and CD2
p16INK4a as target for T cell-based cancer immunotherapy
Mutated neo-antigens as targets for individualized cancer immunotherapy
The complement system as a target in cancer immunotherapy
TOX as a potential target for immunotherapy in lymphocytic malignancies
Oncolytic immunotherapy: unlocking the potential of viruses to help target cancer
Identification of novel immune checkpoints as targets for cancer immunotherapy
Integrative Analysis Revealed LINC00847 as a Potential Target of Tumor Immunotherapy
Pan-cancer analysis reveals IGFL2 as a potential target for cancer prognosis and immunotherapy
Immune checkpoint molecules in natural killer cells as potential targets for cancer immunotherapy
The Notch signaling pathway: a potential target for cancer immunotherapy
NEK2 is a potential pan-cancer biomarker and immunotherapy target
Revisiting T-cell adhesion molecules as potential targets for cancer immunotherapy: CD226 and CD2
p16INK4a as target for T cell-based cancer immunotherapy
Mutated neo-antigens as targets for individualized cancer immunotherapy
The complement system as a target in cancer immunotherapy
TOX as a potential target for immunotherapy in lymphocytic malignancies
Oncolytic immunotherapy: unlocking the potential of viruses to help target cancer
Identification of novel immune checkpoints as targets for cancer immunotherapy
Integrative Analysis Revealed LINC00847 as a Potential Target of Tumor Immunotherapy
Pan-cancer analysis reveals IGFL2 as a potential target for cancer prognosis and immunotherapy
Immune checkpoint molecules in natural killer cells as potential targets for cancer immunotherapy
The Notch signaling pathway: a potential target for cancer immunotherapy
NEK2 is a potential pan-cancer biomarker and immunotherapy target
Revisiting T-cell adhesion molecules as potential targets for cancer immunotherapy: CD226 and CD2
p16INK4a as target for T cell-based cancer immunotherapy
Mutated neo-antigens as targets for individualized cancer immunotherapy
The complement system as a target in cancer immunotherapy
TOX as a potential target for immunotherapy in lymphocytic malignancies
Oncolytic immunotherapy: unlocking the potential of viruses to help target cancer
Identification of novel immune checkpoints as targets for cancer immunotherapy